MRI for prostate adenoma: when it's needed, what it shows, and how to interpret the results

Prostate adenoma is the common name for benign prostatic hyperplasia, a noncancerous enlargement of prostate tissue, most commonly in the transition zone around the urethra. This growth can compress the bladder outlet, causing a weak urine stream, straining, frequent urination, nighttime urination, and a feeling of incomplete urination. [1]

Magnetic resonance imaging of the prostate is not a standard initial investigation for routine, uncomplicated symptoms of benign prostatic hyperplasia. The American College of Radiology states that in the initial evaluation of uncomplicated lower urinary symptoms associated with an enlarged prostate, magnetic resonance imaging of the prostate is not usually indicated; clinical evaluation, questionnaires, urinalysis, residual urine assessment, and ultrasound are often sufficient when indicated. [2]

This is an important practical point: magnetic resonance imaging (MRI) clearly shows the anatomy of the prostate, the gland's zones, suspicious lesions, and volume, but it does not replace the question of "how a man urinates." To assess the functional problem, the doctor needs symptoms, a voiding diary, uroflowmetry, residual urine, and sometimes urodynamic tests, because a weak stream can be associated not only with the prostate but also with bladder muscle weakness or urethral stenosis. [3]

The primary area where prostate magnetic resonance imaging has become particularly important is not the diagnosis of adenoma itself, but the diagnosis of clinically significant prostate cancer in men with a suspicious prostate-specific antigen (PSA) level, abnormal digital rectal examination (DRE), or other risk factors. The European Association of Urology recommends performing MRI before biopsy in men with suspected localized prostate cancer. [4]

Therefore, the correct answer is: for typical symptoms of adenoma, MRI is usually not needed as a first step, but it can be very useful if there is a suspicion of prostate cancer, an ambiguous prostate-specific antigen, a need for more accurate measurement of prostate volume, complex anatomy before the procedure, planning for prostate artery embolization, or discrepancies between complaints and routine examination data. [5]

Table 1. When MRI is not usually the first step

Situation	Why an MRI is usually not needed first
Mild urinary symptoms	First, the questionnaire, urine analysis and observation are more important.
Typical weak stream without red flags	Most often, a basic urological assessment is started.
No increase in prostate-specific antigen	There is no specific oncological reason for MRI.
No blood in urine or infections	Less reason to look for complex pathology
It is necessary to measure residual urine	It's easier to do this with ultrasound.

[6]

Table 2. When MRI may be useful

Situation	Why is an MRI needed?
Suspected prostate cancer	Find lesions for targeted biopsy
Elevated prostate-specific antigen	Clarify the risk of clinically significant cancer
Unclear results from previous examinations	Compare anatomy and symptoms
Planning some procedures	Measure the volume and assess the shape of the prostate
Preparation for prostate artery embolization	Part of preoperative imaging in selected centers

[7]

Table 3. What MRI shows best

What can be seen on an MRI?	Clinical significance
Transitional zone of the prostate	This is where benign hyperplasia often develops.
Peripheral zone	They often look for suspicious cancer sites there.
Prostate volume	Helps choose treatment
Benign hyperplasia nodules	Explain the enlargement of the gland
Suspicious foci	They help decide on a biopsy

[8]

Table 4. What MRI does not replace

Examination	Why is it still needed?
Urine analysis	Rules out infection, blood, sugar in urine
Bladder diary	Shows frequency, volumes, night urine
Uroflowmetry	Measures urine flow rate
Residual urine	Shows whether the bladder is emptying
Symptom questionnaire	Measures the impact of disease on quality of life

[9]

Table 5. The main difference in goals

Target	The best tools
Understand how much the symptoms are bothering you	Questionnaire and voiding diary
Check for infection	Urine analysis
Assess urine flow	Uroflowmetry
Measure residual urine	Ultrasound examination
Search for clinically significant cancer	Multiparametric magnetic resonance imaging and biopsy as indicated

[10]

What exactly does an MRI show in benign prostatic hyperplasia?

In magnetic resonance imaging, the prostate is assessed by zones: the peripheral zone, the transition zone, the central zone, the anterior fibromuscular stroma, and the area around the urethra. Benign prostatic hyperplasia typically develops predominantly in the transition zone, so images often show multiple nodules of varying sizes, which can increase the volume of the gland and alter the shape of the prostatic urethra.

Benign nodules on magnetic resonance imaging often appear as round, well-demarcated, or encapsulated lesions in the transition zone. In the Prostate Imaging Reporting and Data System version 2.1, typical encapsulated transition zone nodules are generally considered benign rather than clinically significant cancer.[11]

The problem is that the transition zone in adenoma becomes difficult to interpret: benign nodules, inflammatory changes, scars, and compressed tissue can mimic suspicious lesions. This is why image quality, the radiologist's experience, and the use of a standardized Prostate Imaging Reporting and Data System are especially important when MRI is used not simply to evaluate prostate volume but to rule out cancer. [12]

Magnetic resonance imaging can also accurately assess prostate volume. This is important because the size of the gland influences treatment choices: for example, 5-alpha-reductase inhibitors make more sense for an enlarged prostate, while the choice between transurethral resection, laser enucleation, aqua ablation, prostatic urethral lift, water vapor therapy, or embolization depends on the volume and anatomy of the gland. [13]

Intravesical protrusion of the prostate, i.e., a situation where the enlarged middle lobe or central portion of the gland protrudes into the bladder, is assessed separately. This can be an important sign of obstruction and may influence the choice of procedure, as not all minimally invasive techniques are equally suitable for protruding middle lobes. [14]

Table 6. Main zones of the prostate on MRI

Zone	Why is it important?
Transition zone	The main zone of benign hyperplasia
Peripheral zone	A common site of clinically significant cancer
Central zone	Important for anatomical orientation
Anterior fibromuscular stroma	May influence the interpretation of anterior lesions
The area around the urethra	Important for obstructive symptoms

[15]

Table 7. Signs of benign hyperplasia on MRI

Sign	What does it mean?
Nodes of the transition zone	Typical picture of adenoma
Enlargement of the prostate	May affect urination and treatment choices
Encapsulated round nodes	Often a benign picture
Average share	May protrude into the bladder
Compression of the urethra	Possible mechanism of weak jet

[16]

Table 8. Why MRI is more difficult to read in adenoma

Cause	Consequence
Many nodes in the transition zone	It is more difficult to distinguish between benign and suspicious
Inflammatory changes	They may give false alarms.
Postoperative scars	They change anatomy
Large prostate	Increases the volume of analysis for the radiologist
Low quality photos	Increases the risk of error

[17]

Table 9. What is important for choosing treatment

Parameter	How does it affect
Prostate volume	Choosing a medication or procedure
Average share	Not every minimally invasive method is suitable
Residual urine	Shows the risk of delay
Urine flow rate	Reflects a functional disorder
Suspicious foci	A biopsy may be required before adenoma treatment.

[18]

Table 10. MRI and ultrasound: which is better for what?

Task	Ultrasound examination	Magnetic resonance imaging
Residual urine	Very convenient	Usually not necessary
Prostate volume	Often enough	More precise and detailed in complex cases
Search for a suspicious cancer lesion	Limited	The main method before biopsy
Estimation of the average share	It is often possible	More details
Initial assessment of symptoms	Yes	Usually no

[19]

When an MRI is needed because of the risk of prostate cancer, and not because of the adenoma itself

The most common reason for ordering a prostate magnetic resonance imaging scan in a man with adenoma is not to confirm the presence of adenoma, but to rule out clinically significant prostate cancer. This is especially true if prostate-specific antigen is elevated, there is a suspicious digital rectal examination, there is a family history of prostate cancer, or a previous biopsy was negative but the suspicion remains. [20]

This is important because benign hyperplasia itself can increase prostate-specific antigen levels due to increased prostate volume. However, a single test cannot reliably determine whether an increase is due solely to benign growth: the physician takes into account age, prostate volume, prostate-specific antigen density, the dynamics of the level, inflammation, medication use, and the results of the examination. [21]

The Prostate Imaging Reporting and Data System version 2.1 is designed to standardize the reporting of prostate magnetic resonance imaging (MRI) findings. It uses categories from one to five, where categories one and two typically represent a low probability of clinically significant cancer, three represent an uncertain probability, and four and five represent a high and very high probability of clinically significant cancer. [22]

If magnetic resonance imaging (MRI) reveals a lesion classified as Prostate Imaging Reporting and Data System (PIRDS) 3, 4, or 5, the urologist decides whether to perform a biopsy. The American Urological Association (AUA) states that MRI before the initial biopsy can be used to enhance the detection of cancers classified as Grade Group 2 or higher, which are clinically more significant. [23]

However, a normal or low-suspicion MRI does not always completely rule out cancer. If the risk remains high due to prostate-specific antigen density, heredity, digital examination, or test dynamics, the doctor may still recommend observation, repeat testing, or biopsy. [24]

Table 11. When MRI is most often prescribed due to oncological alertness

Sign	Why is it important?
Elevated prostate-specific antigen	It may be associated not only with adenoma
Increased prostate-specific antigen	Requires an assessment of the dynamics
Suspicious digital examination	Increases the risk of clinically significant cancer
Family history of prostate cancer	Increases alertness
Previous negative biopsy with ongoing suspicion	MRI helps find missed lesions

[25]

Table 12. Prostate Imaging Reporting and Data System Categories

Category	Simplified meaning
1	Clinically significant cancer is extremely unlikely
2	Clinically significant cancer is unlikely
3	The probability is uncertain
4	Clinically significant cancer is likely
5	Clinically significant cancer is very likely

[26]

Table 13. Why prostate-specific antigen increases not only in cancer

Cause	Comment
Benign prostatic enlargement	The more iron, the higher the indicator can be
Inflammation of the prostate	May temporarily increase the indicator
Urinary tract infection	May distort the assessment
Recent manipulations	Catheterization or biopsy affects the indicator
Prostate cancer	An important reason that cannot be missed

[27]

Table 14. How MRI helps biopsy

Without MRI	With MRI
Biopsy is more often systematic	You can add target samples
The outbreak may be missed	The suspicious area is visible in advance
It's more difficult to explain the risk	There is a category called Prostate Imaging Reporting and Data System.
Less anatomical information	The location of the fire is better visible
It is more difficult to plan a repeat biopsy	You can aim at a specific area

[28]

Table 15. Why MRI doesn't replace the doctor

Situation	What is important
Prostate Imaging Reporting and Data System 1-2	The risk is lower, but not always zero.
Prostate Imaging Reporting and Data System 3	The decision depends on the overall risk
Prostate Imaging Reporting and Data System 4-5	Biopsy is often discussed
Large prostate	An assessment of prostate-specific antigen density is needed.
Urinary symptoms	Not always associated with MRI results

[29]

How is a prostate MRI performed: types of examination, contrast, and preparation

Multiparametric magnetic resonance imaging (MRI) or, in some protocols, biparametric MRI are used to evaluate the prostate. The multiparametric protocol typically includes T2-weighted imaging, diffusion-weighted imaging, a measured diffusion coefficient map, and dynamic contrast enhancement; this combination is required for standardized assessment according to the Prostate Imaging Reporting and Data System. [30]

T2-weighted images are particularly important for prostate anatomy and assessing the transition zone, where benign hyperplasia develops. Diffusion-weighted images help assess the restriction of water molecule movement in tissue, which is used to detect suspicious lesions, and dynamic contrast enhancement can be helpful in certain situations, particularly for refining certain categories.

Contrast is not always required in the same way. In classical multiparametric magnetic resonance imaging, it is included in the protocol, but many centers discuss and implement biparametric protocols without contrast for specific diagnostic purposes, especially when the goal is screening or initial risk assessment. However, the decision regarding contrast is made by the physician and the radiology center, taking into account the purpose of the examination, renal function, allergy history, and local protocol. [31]

Preparation varies by center, but patients are typically asked to remove metal objects, disclose any cardiac pacemakers, neurostimulators, implants, metal fragments, claustrophobia, kidney disease, or allergic reactions to contrast agents. Bowel movements, bladder control, and limiting gas-producing foods are sometimes recommended, as bowel movements and gas can impair image quality. [32]

The MRI results should be structured: prostate volume, description of zones, suspicious lesions with Prostate Imaging Reporting and Data System categories, lesion location, size, signs of protrusion beyond the capsule, and the condition of the seminal vesicles and lymph nodes, if this is part of the examination. It is especially important for the patient not to extract just one line from the report, but to discuss the results with the urologist along with the prostate-specific antigen (PSA) level, PSA density, and symptoms. [33]

Table 16. Basic sequences of prostate MRI

Subsequence	What does it give?
T2-weighted images	Anatomy, zones, and nodes of adenoma
Diffusion-weighted imaging	Search for areas of limited diffusion
Map of the measured diffusion coefficient	Quantitative support for diffusion assessment
Dynamic Contrast Enhancement	Contrast accumulation assessment
Three-dimensional reconstructions according to indications	Planning a biopsy or procedure

[34]

Table 17. When contrast is especially discussed

Situation	Comment
Full multiparametric MRI	Contrast is often included in the standard protocol.
Renal failure	Contrast safety assessment required
History of allergic reactions	It is necessary to inform in advance
Repeated studies	The decision depends on the goal
Biparametric protocol	Can be performed without contrast in certain scenarios

[35]

Table 18. What to report before MRI

Factor	Why is it important?
Pacemaker	Not all devices are compatible with MRI.
Metal implants	Security check required
Claustrophobia	We can discuss assistance in advance.
Kidney disease	Important for contrast
Previous biopsy or surgery	Changes the interpretation of photographs

[36]

Table 19. What should be in a good conclusion

Element	Why is it needed?
Prostate volume	For prostate-specific antigen density and treatment
Description of the transition zone	For adenoma and suspicious lesions
Category: Prostate Imaging Reporting and Data System	To assess the risk of cancer
Size and location of the lesion	For targeted biopsy
Additional signs of spread	For oncological tactics, if cancer is probable

[37]

Table 20. What can worsen the quality of MRI

Cause	Consequence
Patient movement	Blurry images
Gas in the rectum	Artifacts in the prostate area
Recent biopsy	Hemorrhages may interfere with assessment
Metal implants near the pelvis	Image distortion
Low protocol quality	Decreased reliability of the Prostate Imaging Reporting and Data System

[38]

MRI before treatment of prostate adenoma: medications, surgery, and prostate artery embolization

Magnetic resonance imaging is usually not necessary for drug prescription. For example, when choosing an alpha-1 blocker, symptoms, blood pressure, tolerability, and the risk of side effects are more important, while when choosing a 5-alpha reductase inhibitor, it is important to confirm that the prostate is indeed enlarged; ultrasound or existing imaging is often sufficient for this. [39]

However, accurate prostate volume is important. The American Urological Association notes that objective assessment of prostate size is reasonable when treatment decisions depend on gland volume, such as with 5-alpha-reductase inhibitors or procedure selection; this can be accomplished using transrectal ultrasound or existing cross-sectional imaging, including magnetic resonance imaging or computed tomography. [40]

Preoperative magnetic resonance imaging (MRI) can be useful for more precise assessment of volume, midlobe, transition zone shape, suspicious lesions, or complex anatomy. However, in a typical transurethral resection (TURP) or laser surgery, the physician often relies on ultrasound, cystoscopy, uroflowmetry, and symptomatic data rather than ordering MRI for every patient. [41]

A special situation is prostate artery embolization. In 2026, the Society of Interventional Radiology published a practice guideline for prostate artery embolization and stated that prostate size should be assessed before the procedure using ultrasound or cross-sectional imaging, including magnetic resonance imaging or computed tomography. [42]

Prostate artery embolization has become a more accepted option for selected patients with symptomatic benign prostatic hyperplasia, but it requires careful selection and a multidisciplinary approach. The Society of Interventional Radiology (SIRR) in 2026 emphasized that new guidelines address clinical assessment, diagnostic and preoperative imaging, and treatment selection for a specific diagnosis. [43]

Table 21. Is it necessary to do an MRI before taking medications?

Medicine	Is an MRI usually necessary?
Alpha-1-adrenergic blocker	Usually no
5-alpha-reductase inhibitor	Prostate volume is needed, but ultrasound is often sufficient
Tadalafil	Usually no
Medications for overactive bladder	Residual urine is more important
Combination treatment	An assessment of the risk of progression is needed; MRI is not always necessary

[44]

Table 22. When prostate volume influences treatment

Clinical decision	Why is volume needed?
Prescribing a 5-alpha-reductase inhibitor	More benefits with enlarged glands
Selecting an operation	Methods vary in optimal size
Choosing a minimally invasive procedure	Some methods have limitations due to anatomy
Prostate-specific antigen density assessment	Prostate volume required
Embolization planning	It is necessary to evaluate the size and anatomy

[45]

Table 23. The role of MRI before surgical treatment

Task	Benefits of MRI
Suspected cancer before surgery	Helps decide on a biopsy
Very large prostate	Estimates volume more accurately
Compound middle share	Shows anatomy better
After previous operations	Helps to understand altered anatomy
Choosing between procedures	Provides additional information but does not replace a urologist

[46]

Table 24. MRI and embolization of prostate arteries

Stage	How MRI can help
Patient selection	Prostate size assessment
Planning	Anatomy of the gland and nodes
Exclusion of other pathology	Suspicious lesions require evaluation.
Result control	Comparison of volume before and after
Interdisciplinary discussion	A urologist and interventional radiologist compare data

[47]

Table 25. What information is important for the doctor before the procedure?

Data	Why are they needed?
International Prostate Symptom Scale	How severe are the complaints?
Uroflowmetry	How much is the flow disrupted?
Residual urine	Risk of delayed and incomplete emptying
Prostate volume	Selecting a method
Prostate cancer risk	Is an MRI and biopsy necessary before treatment?

[48]

How to Read an MRI: Volume, Prostate Imaging Reporting and Data System, and PSA Density

In a prostate magnetic resonance imaging report, patients most often see the volume of the prostate gland, a description of benign hyperplasia, possible signs of prostatitis, the Prostate Imaging Reporting and Data System category, and sometimes the prostate-specific antigen density. These items serve different purposes: volume is helpful in identifying adenoma, the Prostate Imaging Reporting and Data System category helps assess the risk of clinically significant cancer, and the prostate-specific antigen density correlates the blood test with the size of the prostate gland. [49]

Prostate volume is usually reported in milliliters or cubic centimeters. For the patient, not only the absolute figure is important, but also the relationship with symptoms: a large prostate increases the likelihood of obstruction and progression, but does not always directly explain all complaints; a small or moderate prostate can also cause significant symptoms if there is a medial lobe, spasm, inflammation, overactive bladder, or detrusor weakness. [50]

The Prostate Imaging Reporting and Data System category is not an "adenoma stage." It is a scale for the probability of clinically significant prostate cancer on magnetic resonance imaging. Therefore, the phrase "prostate adenoma, Prostate Imaging Reporting and Data System 2" usually means that benign changes are present, but there are few signs of clinically significant cancer on MRI; however, the final interpretation should be made taking into account prostate-specific antigen and clinical risk. [51]

Prostate-specific antigen density (PSA) is the ratio of PSA levels to prostate volume. It helps understand the extent to which test results are "explained" by the size of the gland; in a large prostate, a moderately elevated PSA may be less concerning than the same value in a small gland. [52]

The conclusion may also contain the words "benign hyperplasia nodules," "transitional zone changes," "prostatitis-like changes," "no extracapsular extension detected," and "seminal vesicles normal." These phrases should not be interpreted separately from the entire conclusion: for example, benign nodules are not the same as cancer, and the absence of a suspicious lesion does not always cancel observation if the overall risk remains high. [53]

Table 26. What does prostate volume mean?

Volume	Possible meaning
Small	Symptoms may not only be due to volume
Moderately enlarged	Benign hyperplasia is possible
Big	Higher risk of progression and urinary retention
Very big	Affects the choice of surgery or procedure
Volume plus symptoms	More important than the volume itself

[54]

Table 27. What does the Prostate Imaging Reporting and Data System category mean?

Category	Simplified interpretation
1	There are almost no suspicious signs.
2	Clinically significant cancer is unlikely
3	Uncertain result
4	Suspicion is high
5	The suspicion is very high

[55]

Table 28. How volume differs from category Prostate Imaging Reporting and Data System

Indicator	Answers the question
Prostate volume	How much is the gland enlarged?
Transition zone	Is there a picture of adenoma?
Average share	Could there be a mechanical obstruction?
Prostate Imaging Reporting and Data System	Is there a suspicion of clinically significant cancer?
Prostate-specific antigen density	How well does a blood test correspond to the size of the gland?

[56]

Table 29. Why Prostate Imaging Reporting and Data System 3 Requires Discussion

Factor	How does it affect
Prostate-specific antigen density	May increase or decrease anxiety
Family history	Increases the risk
Age	Changes the clinical context
Location of the hearth	Affects the probability and biopsy
Radiologist experience	Important for the transition zone

[57]

Table 30. What questions to ask your doctor after an MRI

Question	For what
What is my prostate volume?	Understand the impact on treatment
Is there a middle ground?	Important for the procedure
What is the Prostate Imaging Reporting and Data System category?	Assess cancer risk
Is a biopsy necessary?	The decision depends on the overall risk
Does the MRI explain my symptoms?	Not all complaints are visible in the images

[58]

Limitations and Risks of MRI: Why 'Just in Case' Isn't Always Best

Magnetic resonance imaging is a powerful tool, but it is not a perfect filter. It can produce false-positive results when a benign nodule, inflammation, or technical artifact appears suspicious; this can lead to anxiety, additional consultations, and biopsy. [59]

False negative results are also possible. Some clinically significant tumors may be subtle, complexly located, or lack typical imaging features; therefore, a high clinical risk should not be completely ignored simply because an MRI scan appears normal. [60]

The quality of the examination depends heavily on the protocol, the equipment, patient movement, bowel artifacts, the quality of diffusion images, and the experience of the radiologist. Therefore, the same term "prostate MRI" in different centers does not always mean the same diagnostic value, especially if the examination is performed to assess suspected cancer, and not just the volume of the gland. [61]

Magnetic resonance imaging (MRI) also doesn't directly show the strength of bladder contraction. If a man has a weak stream due to a weak detrusor (the bladder muscle), the scan may show an enlarged prostate, but the true cause of poor voiding will be mixed or different. In such cases, uroflowmetry, residual urine, and sometimes urodynamic testing are needed. [62]

Finally, MRI is a more expensive and less accessible method than ultrasound, and it should not delay care in acute conditions. If a man is unable to urinate at all, has severe pain, infection, blood in the urine, or signs of kidney damage, the urgent clinical problem should be addressed first, rather than waiting for a scheduled MRI scan. [63]

Table 31. Limitations of MRI

Limitation	What does it mean
False positive lesions	Not every suspicious area is cancer.
False negative results	A normal MRI does not always provide zero risk.
Dependence on protocol quality	The center's experience is important
Does not measure urination	Functional tests are needed
Not always available quickly	Should not delay emergency assistance

[64]

Table 32. What can mimic cancer on MRI

Cause	Why is it confusing?
Benign hyperplasia nodule	It can be dense and heterogeneous
Inflammation	May limit diffusion
Cicatricial changes	They change the structure of the tissue
Hemorrhage after biopsy	Distorts the signal
Artifacts	Create false suspicious areas

[65]

Table 33. When MRI may not resolve the issue

Situation	What you might need
Prostate Imaging Reporting and Data System 3	Risk assessment and sometimes biopsy
High density prostate-specific antigen	Further discussion
Severe symptoms with a small prostate	Functional diagnostics
High residual urine	Uroflowmetry and urodynamics according to indications
Blood in urine	Separate diagnostic algorithm

[66]

Table 34. Why is center quality important?

Factor	Meaning
Standardized protocol	Needed for a reliable assessment
Radiologist experience	Particularly important in the transition zone
Quality of diffusion images	Affects the risk category
Structured conclusion	Helps the urologist make a decision
Relationship with biopsy	Needed for targeted tissue sampling

[67]

Table 35. When a scheduled MRI cannot be expected

Symptom	What to do
Inability to urinate	See a doctor immediately
Severe pain in the lower abdomen	Eliminate urinary retention
Temperature and painful urges	Rule out infection
Blood in urine	Urgent examination
Signs of deteriorating kidney function	Rapid medical assessment

[68]

Practical algorithm: what to do for a patient who has been prescribed an MRI for prostate adenoma

The first step is to clarify the purpose of the examination. You should directly ask your doctor whether the MRI is being ordered to rule out cancer, to determine prostate volume, to plan surgery, to perform prostate artery embolization, or because of discrepancies between symptoms and routine examinations. The protocol, the need for contrast, and the subsequent interpretation of the results depend on the purpose. [69]

The second step is to collect pre-MRI data: prostate-specific antigen level, test date, digital rectal examination results, urinalysis, ultrasound results, prostate volume, residual urine, urine flow rate, and medication list. Without this data, even a good MRI can be misinterpreted because the image shows the anatomy but not the full clinical context. [70]

The third step is to not just say "there's an adenoma" or "Prostate Imaging Reporting and Data System 2" after receiving the diagnosis. You need to discuss with your urologist whether your prostate volume corresponds to your prostate-specific antigen level, whether your anatomy explains your symptoms, whether there are any suspicious lesions, whether a biopsy is needed, whether treatment can be done with pills, or whether it's better to discuss the procedure. [71]

The fourth step is to compare the MRI with functional tests if it was performed prior to adenoma treatment. A large prostate on the scan does not always mean it is entirely responsible for the symptoms; if there is frequent urgency, nocturia, or incontinence, a bladder evaluation and voiding diary may be necessary. [72]

The fifth step is not to use MRI as a substitute for observation. If drug therapy is chosen, monitoring depends on the drug: with alpha-1-adrenergic blockers, the effect is assessed after weeks, with 5-alpha-reductase inhibitors, after months, and with procedures, symptoms, urine flow, and residual urine after recovery are monitored. [73]

Table 36. What documents should you take to an MRI or to a urologist?

Document	For what
Prostate-specific antigen	Risk and indicator density assessment
Previous ultrasound examinations	Comparison of prostate volume
Urine analysis	Exclusion of infection and blood
Uroflowmetry results	Evaluation of urine flow
List of medications	Search for factors that worsen urination

[74]

Table 37. What to ask before the study

Question	Why is it important?
Is this an MRI for cancer or adenoma?	Different purposes of interpretation
Is contrast necessary?	Depends on the protocol and risk
Will there be a report on the Prostate Imaging Reporting and Data System?	Important if cancer is suspected
Do I need to bring old photos?	Helps to compare dynamics
When to discuss the results with a urologist?	MRI itself is not a treatment plan

[75]

Table 38. What to discuss after the conclusion

Paragraph	A practical question
Prostate volume	Do you need a prostate shrinking drug?
Average share	Which treatment method is suitable?
Category: Prostate Imaging Reporting and Data System	Is a biopsy necessary?
Prostate-specific antigen density	How alarming is the analysis?
Residual urine	Is there a risk of delay?

[76]

Table 39. Possible solutions after MRI

Result	Possible tactics
Large prostate without suspicious lesions	Medication or procedure based on symptoms
Prostate Imaging Reporting and Data System 1-2	Monitoring or treatment of adenoma according to risk
Prostate Imaging Reporting and Data System 3	Individual biopsy decision
Prostate Imaging Reporting and Data System 4-5	Targeted biopsy is often discussed
Complex anatomy	The choice of treatment method is being reviewed

[77]

Table 40. What not to do

Error	Why is it bad?
Doing an MRI without a purpose	You can get an expensive result that doesn't change tactics
Treat only the image	Bladder symptoms and function are equally important.
Ignore high prostate-specific antigen	Adenoma does not rule out cancer
Stop taking medications on your own	Urination or pressure may worsen.
Wait for an MRI if you have urinary retention	This is an urgent situation.

[78]

FAQ

Should all men with prostate adenoma have an MRI? No. For routine, uncomplicated lower urinary symptoms, prostate MRI is not usually the first test performed; instead, the initial evaluation is usually based on symptoms, urinalysis, residual urine assessment, uroflowmetry, and ultrasound, if indicated. [79]

When is MRI really necessary for prostate adenoma? It is especially useful if there is a suspicion of prostate cancer, elevated or ambiguous prostate-specific antigen, the need for a targeted biopsy, complex anatomy, planning of specific procedures, or preparation for prostate artery embolization. [80]

Does MRI show prostate adenoma? Yes, MRI can show prostate enlargement, transition zone nodules, the middle lobe, and the volume of the gland. However, the presence of adenoma can often be determined by simpler methods, so MRI is usually needed not to confirm enlargement, but for specific clinical purposes. [81]

Can MRI tell you how poorly a patient is voiding? Not completely. MRI shows anatomy, but it does not measure urine flow, bladder contractility, or residual urine over time; these require uroflowmetry, ultrasound assessment of residual urine, a voiding diary, and sometimes urodynamic testing. [82]

What is the Prostate Imaging Reporting and Data System? It is a standardized system for describing prostate magnetic resonance imaging (MRI) scans that helps assess the likelihood of clinically significant prostate cancer in categories one through five. It is not a severity scale for prostate adenoma. [83]

If the report states Prostate Imaging Reporting and Data System 2, is cancer completely excluded? No, the probability of clinically significant cancer is usually low, but not absolute zero. The final decision depends on the prostate-specific antigen (PSA) level, its density, digital examination, family history, and follow-up dynamics. [84]

If the report says Prostate Imaging Reporting and Data System 4 or 5, is it definitely cancer? No, this is a high or very high level of suspicion, but a cancer diagnosis is only confirmed histologically, that is, after a biopsy. Benign nodules and inflammation can sometimes mimic suspicious lesions. [85]

Is contrast required for prostate MRI? Contrast is often included in the protocol for classic multiparametric MRI, but in some cases, biparametric protocols without contrast are used. The decision depends on the purpose of the examination, kidney function, history of allergic reactions, and the center's protocol. [86]

Is it possible to have an MRI after a prostate biopsy? It is possible, but a recent biopsy may leave hemorrhages and artifacts that interfere with interpretation. Therefore, it is best to coordinate the timing of the examination after the biopsy with a urologist and radiologist. [87]

Is MRI better than prostate ultrasound? Not in the sense of "always better." Ultrasound is simpler, less expensive, and convenient for residual urine and basic assessment; MRI offers more detail for prostate areas, suspicious lesions, complex anatomy, and planning specific interventions. [88]

Is MRI necessary before prostate artery embolization? Before embolization, prostate size should be assessed using ultrasound or cross-sectional imaging, including magnetic resonance imaging (MRI) or computed tomography (CT). The specific imaging modalities used depend on the center and the interventional radiologist. [89]

What's more important for adenoma treatment: MRI or symptoms? Both are important, but symptoms, quality of life, urinary flow, and residual urine determine the clinical problem, while MRI adds anatomical and oncological information. It's the patient, not the image, that should be treated. [90]

Key points from experts

Professor Jean-Nicolas Louis Cornu, Chairman of the European Association of Urology's Expert Panel on Non-Neurogenic Lower Urinary Symptoms in Men. Key message: urinary symptoms in men cannot be simply diagnosed with adenoma, as lower urinary symptoms can be related to the prostate, bladder, urethra, and systemic factors; MRI should be used clinically, not automatically. [91]

Ramy Goueli, MD, urologist, co-author of the 2026 American Urological Association guideline on lower urinary symptoms associated with benign prostatic hyperplasia. Key message: Standard initial evaluation focuses on symptoms, urinalysis, shared decision making, and residual urine and uroflowmetry when indicated; prostate imaging is indicated when its results influence treatment decisions. [92]

Franklin C. Lowe, Leslie F. Alexander, et al., American College of Radiology appropriateness criteria for lower urinary tract symptoms. Key message: For uncomplicated lower urinary tract symptoms due to an enlarged prostate, magnetic resonance imaging is not usually part of the initial evaluation, and ultrasound may be appropriate for evaluation of the bladder and residual urine.[93]

American College of Radiology, European Society of Urogenital Radiology, and AdMeTech Foundation Expert Group on Prostate Imaging Reporting and Data System version 2.1. Key message: Prostate magnetic resonance imaging should be performed and reported in a standardized manner because the Prostate Imaging Reporting and Data System categories help assess the likelihood of clinically significant cancer but are not a scale for the severity of adenoma. [94]

Jafar Golzarian, Ziv J Haskal, Sandeep Bagla, and co-authors of the 2026 Society of Interventional Radiology guideline for prostate artery embolization. Key message: When planning prostate artery embolization, prostate size assessment by ultrasound or cross-sectional imaging, including magnetic resonance imaging or computed tomography, is necessary; patient selection should be clinically informed.[95]